Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Worldwide Healthcare's Sven Borho makes share purchase

(Sharecast News) - Worldwide Healthcare revealed on Friday that non-executive director Sven Borho had acquired 50,000 ordinary shares in the London-listed healthcare investor. Borho, who founded OrbiMed, acquired the shares on Thursday at an average price of 322.0p each, for a total value of £161,000.

As of 1630 GMT, Worldwide Healthcare shares were up 0.93% at 326.50p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Worldwide Healthcare Trust (WWH) Director name: Borho,Sven Amount purchased: 50,000 @ 322.00p Value: £161,000.00

Frp Advisory Group (FRP) Director name: Judd,Penelope Ruth Amount purchased: 39,995 @ 125.00p Value: £49,993.75

Prs Reit (the) (PRSR) Director name: Smith,Stephen Amount purchased: 45,000 @ 77.24p Value: £34,756.34

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 50,000 @ 24.00p Value: £12,000.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 50,000 @ 23.31p Value: £11,655.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 50,000 @ 22.84p Value: £11,417.50

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 35,000 @ 24.50p Value: £8,575.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 33,000 @ 24.60p Value: £8,118.00

Fiske (FKE) Director name: Perrin,Martin Henry Withers Amount purchased: 10,600 @ 65.00p Value: £6,890.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 25,000 @ 26.00p Value: £6,500.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 25,000 @ 25.30p Value: £6,325.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 25,000 @ 23.64p Value: £5,909.75

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 25,000 @ 22.77p Value: £5,692.18

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 17,000 @ 24.50p Value: £4,165.00

Theworks.co.uk (WRKS) Director name: Goold,John Amount purchased: 10,000 @ 25.50p Value: £2,550.00

Ocado Group (OCDO) Director name: Abrams,Neill Amount purchased: 29 @ 532.80p Value: £154.51

British Land Company (BLND) Director name: Mistry,Bhavesh Amount purchased: 40 @ 373.45p Value: £149.38

British Land Company (BLND) Director name: Carter,Simon Amount purchased: 40 @ 373.45p Value: £149.38

Ocado Group (OCDO) Director name: Daintith,Stephen Amount purchased: 28 @ 532.80p Value: £149.18

Ocado Group (OCDO) Director name: Steiner,Tim Amount purchased: 28 @ 532.80p Value: £149.18

Bp (BP.) Director name: Thomson ,Kate Amount purchased: 93,377 @ n/a Value: n/a

Bp (BP.) Director name: Thomson ,Kate Amount purchased: 69,169 @ n/a Value: n/a

Bp (BP.) Director name: Auchincloss,Murray Amount purchased: 6,382 @ n/a Value: n/a

Top Director Sells

Imperial Brands (IMB) Director name: Bomhard ,Stefan Amount sold: 140,219 @ 1,843.00p Value: £2,584,235.68

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.